CHINESE ANTIBODY SOCIETY INC (EIN 813513216) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

YUFANG SHAO

Phone

6463316151

Tax Period

2022-07-01 to 2023-06-30

CHINESE ANTIBODY SOCIETY INC, founded in 2016, is a small nonprofit in the Diseases & Disorders sector that reported $405K in total revenue in fiscal year 2022. Revenue surged 168% from the prior year, signaling strong growth momentum. Expenses of $355K left a modest 12% surplus.

Mission

CHINESE ANTIBODY SOCIETY (THE ORGANIZATION") IS AN ORGANIZATION LOCATED IN CAMBRIDGE,MASSACHUSETTS, DEDICATED TO ADVANCE PUBLIC KNOWLEDGE OF THERAPEUTIC ANTIBODIES AND RELATED APPLICATION, AND SUPPORT AND PROMOTE ANTIBODY DRUG-BASED THERAPIES. WE ALSO PROVIDE COMMUNICATION AND NETWORKING PLATFORMS AND OPPORTUNITIES FOR GLOBAL MEMBERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $401,903

Program Service Revenue $0

Investment Income $3,309

Other Revenue $0

TOTAL REVENUE $405,212

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $350,070

Other Expenses $355,081

TOTAL EXPENSES $355,081

Year-over-Year Comparison

	2022	2021	Change
Revenue	$405,212	$150,987	+1.7%
Expenses	$355,081	$55,675	+5.4%
Net Income	$50,131	$95,312	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PENG LIN	PRESIDENT	5.00	Officer Director	$0	$0	$0
YUFANG SHAO	TREASURER	1.00	Officer Director	$0	$0	$0
SHOUYE WANG	DIRECTOR	1.00	Director	$0	$0	$0
MITCHELL HO	DIRECTOR	1.00	Director	$0	$0	$0
GUODONG HUI	CLERK	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$405,212	$355,081	$402,279	$50,131
2022	$150,987	$55,675	$350,723	$95,312
2021	$92,029	$38,479	$254,911	$53,550
2020	$128,477	$124,107	$204,285	$4,370
2019	$254,697	$243,329	$205,414	$11,368
2018	$285,096	$148,167	$195,277	$136,929

CHINESE ANTIBODY SOCIETY INC